32 related articles for article (PubMed ID: 12621611)
1. Novel Multiplexed High Throughput Screening of Selective Inhibitors for Drug-Metabolizing Enzymes Using Human Hepatocytes.
Liu J; Vernikovskaya D; Bora G; Carlo A; Burchett W; Jordan S; Tang LWT; Yang J; Che Y; Chang G; Troutman MD; Di L
AAPS J; 2024 Mar; 26(3):36. PubMed ID: 38546903
[TBL] [Abstract][Full Text] [Related]
2. Monitoring compound integrity with cytochrome P450 assays and qHTS.
MacArthur R; Leister W; Veith H; Shinn P; Southall N; Austin CP; Inglese J; Auld DS
J Biomol Screen; 2009 Jun; 14(5):538-46. PubMed ID: 19483146
[TBL] [Abstract][Full Text] [Related]
3. High-Throughput Liquid Chromatographic Analysis Using a Segmented Flow Injector with a 1 s Cycle Time.
Makey DM; Diehl RC; Xin Y; Murray BE; Stoll DR; Ruotolo BT; Grinias JP; Narayan ARH; Lopez-Carillo V; Stark M; Johnen P; Kennedy RT
Anal Chem; 2023 Nov; 95(46):17028-17036. PubMed ID: 37943345
[TBL] [Abstract][Full Text] [Related]
4. Baihe Zhimu formula attenuates the efficacy of tamoxifen against breast cancer in mice through modulation of CYP450 enzymes.
Li H; Wu C; Liu Y; Zhang S; Gao X
BMC Complement Altern Med; 2019 Sep; 19(1):240. PubMed ID: 31484532
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of lanosterol and its major metabolite FF-MAS in an inhibition assay of CYP51 by azoles with atmospheric pressure photoionization based LC-MS/MS.
Trösken ER; Straube E; Lutz WK; Völkel W; Patten C
J Am Soc Mass Spectrom; 2004 Aug; 15(8):1216-21. PubMed ID: 15276168
[TBL] [Abstract][Full Text] [Related]
6. A review of LC-MS techniques and high-throughput approaches used to investigate drug metabolism by cytochrome P450s.
Youdim KA; Saunders KC
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(17-18):1326-36. PubMed ID: 20207203
[TBL] [Abstract][Full Text] [Related]
7. Use of stable isotope labeled probes to facilitate liquid chromatography/mass spectrometry based high-throughput screening of time-dependent CYP inhibitors.
Dasgupta M; Tang W; Caldwell GW; Yan Z
Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2177-85. PubMed ID: 20583325
[TBL] [Abstract][Full Text] [Related]
8. Validated method for rapid inhibition screening of six cytochrome P450 enzymes by liquid chromatography-tandem mass spectrometry.
Li X; Chen X; Li Q; Wang L; Zhong D
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):128-37. PubMed ID: 17267297
[TBL] [Abstract][Full Text] [Related]
9. High-throughput, 384-well, LC-MS/MS CYP inhibition assay using automation, cassette-analysis technique, and streamlined data analysis.
Halladay JS; Delarosa EM; Tran D; Wang L; Wong S; Khojasteh SC
Drug Metab Lett; 2011 Aug; 5(3):220-30. PubMed ID: 21867481
[TBL] [Abstract][Full Text] [Related]
10. Validation of cytochrome P450 time-dependent inhibition assays: a two-time point IC50 shift approach facilitates kinact assay design.
Perloff ES; Mason AK; Dehal SS; Blanchard AP; Morgan L; Ho T; Dandeneau A; Crocker RM; Chandler CM; Boily N; Crespi CL; Stresser DM
Xenobiotica; 2009 Feb; 39(2):99-112. PubMed ID: 19255936
[TBL] [Abstract][Full Text] [Related]
11. Rapid determination of six metabolites from multiple cytochrome P450 probe substrates in human liver microsome by liquid chromatography/mass spectrometry: application to high-throughput inhibition screening of terpenoids.
He F; Bi HC; Xie ZY; Zuo Z; Li JK; Li X; Zhao LZ; Chen X; Huang M
Rapid Commun Mass Spectrom; 2007; 21(5):635-43. PubMed ID: 17279482
[TBL] [Abstract][Full Text] [Related]
12. High-throughput cytochrome p450 inhibition assays by ultrafast gradient liquid chromatography with tandem mass spectrometry using monolithic columns.
Peng SX; Barbone AG; Ritchie DM
Rapid Commun Mass Spectrom; 2003; 17(6):509-18. PubMed ID: 12621611
[TBL] [Abstract][Full Text] [Related]
13. Recent development in high-throughput bioanalytical support for in vitro ADMET profiling.
Shou WZ; Zhang J
Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):321-36. PubMed ID: 20163321
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
